Updated:
Sanara Ventures
Sanara Ventures is a venture capital based in Ra'anana, founded 2015; the Altss profile covers its classification, headquarters, registration, AUM band, and...
Sanara Ventures
The meaning of Sanara: “Sanare” in Latin means to heal and to cure and to put things “right” in a harmonious way.
General information
Firm type
Venture Capital
Year founded
2015
AUM
Undisclosed
Location
Region
Middle East
Country
Israel
City
Ra'anana
Corporate office
HaPnina St 8, Ra'anana, Israel 4321544
Principals
Assaf Barnea
Founder & Managing Partner
Yoav Shaked
Venture Partner
Efi Hershkovitz
Venture Partner Israel/UK
Dr. Janette Lazarowitz
Chief Biology Officer
Dr. Eran Toledo
CTO
Eli Yered
CFO
Prof. Pinny Halpern
CMO
Andrei Soran
Venture Partner US
Daniel Kahn
Venture Partner EU
Haisong Tang
Venture Partner China
Tal Menipaz
Venture Partner
David Ben-Ami
Venture Partner
Dr. Jan Kimpen
Venture Partner
Dr. Jonathan Seah
Venture Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Sanara Ventures?
Founder and Managing Partner Assaf Barnea leads investment decisions, supported by a venture-partner team spanning Israel, the US, Europe, and China. The firm does not publicly detail a formal investment committee, but Barnea's role as both founder of the 2015 seed platform and the 2023 follow-on fund indicates centralized decision-making.
How is Sanara Ventures related to Sanara Capital?
Sanara Capital is the follow-on fund launched in 2023, targeting Series A and B rounds in Israeli-linked health-tech startups. Sanara Ventures, established in 2015, is the seed-stage platform. Together they manage a combined portfolio of nearly 20 active companies, and both operate under the Sanara brand with the same managing partner.
What is Sanara's relationship with Teva and Philips?
Teva Pharmaceuticals and Philips Healthcare are founding strategic partners that have backed Sanara Ventures since its 2015 launch. They do not function as limited partners in the traditional sense but provide industry connections, market understanding, and support across digital health, medical devices, and bio-convergence for portfolio companies (per the firm).
Does Sanara participate in fund commitments or only direct deals?
Sanara operates exclusively as a direct investor. The firm runs two dedicated vehicles — a seed-stage platform and a Series A/B fund — and does not publicly indicate any fund-of-funds activity or LP commitments to external managers. All capital is deployed into company-level equity rounds.
Which sectors does Sanara explicitly avoid?
Sanara focuses tightly on digital health, bio-convergence, and medical devices; the firm's public materials do not mention any activity in therapeutics, diagnostics outside its device-and-software lens, or health services outside technology-enabled care delivery. It does not appear to invest in generalist tech or non-healthcare verticals.
What is Sanara's known posture on co-investments alongside external GPs?
Sanara does not publicly market a co-investment program, but its venture-partner network across the US, Europe, China and Israel suggests the firm syndicates rounds with regional and sector-specialist investors. The website highlights strategic support from Teva and Philips rather than a formal co-investor club, so co-investment activity appears opportunistic rather than structured.
Does Sanara maintain philanthropic structures?
There is no public disclosure of a philanthropic foundation or donor-advised fund associated with Sanara Ventures or Assaf Barnea. The firm's public footprint is limited to its investment vehicles.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: